RESEARCH USE ONLY — Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Human or veterinary use prohibited.
Third-party verified

Certificates of Analysis

Every nasQ research compound is verified by an independent third-party laboratory using HPLC and mass spectrometry — identity and purity, batch by batch.

9 compounds · independent lab · HPLC & mass spec

BPC-157

10 mg · Pentadecapeptide
99.7%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02162
Lab IDBPC-119_D
Net peptide12.92 mg
AnalyzedSep 9, 2026

CJC-1295

10 mg · GHRH analog (no DAC)
99.6%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02164
Lab IDCJC-023_D
Net peptide13.29 mg
AnalyzedSep 10, 2026

Ipamorelin

10 mg · Pentapeptide secretagogue
99.7%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02166
Lab IDIPA-041_D
Net peptide9.96 mg
AnalyzedSep 10, 2026

KPV

10 mg · α-MSH tripeptide fragment
99.5%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02167
Lab IDKPV-053_D
Net peptide12.66 mg
AnalyzedSep 10, 2026

MOTS-c

10 mg · Mitochondrial-derived peptide
99.7%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02168
Lab IDMOTS-150_D
Net peptide13.05 mg
AnalyzedSep 10, 2026

Retatrutide

10 mg · Triple-receptor agonist
99.7%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02169
Lab IDRET-493_D
Net peptide10.10 mg
AnalyzedSep 10, 2026

Retatrutide

20 mg · Triple-receptor agonist
99.5%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02170
Lab IDRET-492_D
Net peptide19.79 mg
AnalyzedSep 10, 2026

TB-500

10 mg · Thymosin β4 fragment
99.6%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02163
Lab IDTB-054_D
Net peptide11.73 mg
AnalyzedSep 10, 2026

Tesamorelin

10 mg · GHRH analog
99.7%HPLC-MS/MS
Identity + Purity
LabSideChain Analytics
Report No.COA-2026-SC-02171
Lab IDTES-099_D
Net peptide10.93 mg
AnalyzedSep 10, 2026